Pharma To Market is a leading regulatory affairs consulting company operating in the Asia-Pacific region.
Pharma To Market’s client relationships are built on trust, transparency and reliability, which we achieve through our commitment to quality and excellence.
Health Authority Meetings
“The Pharmaceutical Regulatory Affairs and Pharmacovigilance Asia Workshop organised by Pharma To Market was very informative. The workshop met my objectives and I especially enjoyed the interesting segments on Lifecycle Management and Innovation in RA . I came away with valuable new ideas on how to operate in this dynamic industry with ever-changing regulations and I would definitely recommend this workshop to my friends and colleagues.”
Otsuka Pharmaceuticals, Singapore
“The (Authoring eCTD Compliant Documents) workshop was an excellent overview of the documentation requirements for NeeS/eCTD submissions. The ‘hands on’ part of the training highlighted many features within Microsoft Word and Adobe Acrobat which will assist us in producing compliant documentation efficiently in preparation for future eCTD submissions in Australia.”
Dr Danielle McLennan
Generic Partners Pty Ltd, Australia
“We chose to work with Pharma To Market to register our products and the experience was excellent. Pharma To Market provided an insightful overview of the registration requirements to aid our understanding of the process. They also took initiatives to identify potential areas of concern. The result was less time spent on the registrations and that allowed us to promptly and efficiently place our brands on the local market.”
AFT Pharmaceuticals Limited, New Zealand
“As a mid-sized biopharmaceutical company, we can maximize the value we create for patients by working with partners who effectively extend our reach. Such is the case working with Pharma To Market who has delivered a product registration in Singapore each year since we started our partnership. Pharma to Market works independently with consistency – allowing my in-house team to focus on essential internal collaboration and strategic decision-making. This professionalism builds trust, so when we needed to have Pharma to Market manage product registration in a third country that we did not yet have a significant presence ourselves, it gave us complete peace of mind.”
Boon Heon Tan
UCB, Asia Pacific Rim & India